Systems Pharmacology (SP)

PI-123 - A MECHANISTIC QUANTITATIVE SYSTEMS PHARMACOLOGY FRAMEWORK FOR MODEL-INFORMED TRANSLATIONAL ASSESSMENT OF MESENCHYMAL STEM CELL THERAPY IN LUPUS NEPHRITIS

PI-124 - AN INTEGRATED ANALYSIS OF FOUR TARGETED THORIUM CONJUGATES TO ASSESS THE TH-227 AND RA-223 DISTRIBUTION AND TISSUE-RELATED RADIATION.

PI-125 - QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING OF LONCASTUXIMAB TESIRINE-LPYL COMBINED WITH T CELL-DEPENDENT BISPECIFIC ANTIBODIES BRIDGES KNOWLEDGE AND DOSE REGIMEN STRATEGY FOR PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA

PII-123 - A STUDY ON THE PREVALENCE OF CHRONIC CANNABINOID USE INDUCING HYPEREMESIS SYNDROME

PII-124 - PREDICTION OF CLINICAL OUTCOMES IN A HETEROGENOUS NSCLC VIRTUAL PATIENT POPULATION: A QUANTITATIVE SYSTEMS PHARMACOLOGY APPROACH.

PII-125 - QUANTITATIVE SYSTEMS TOXICOLOGY (QST) MODELING USING BIOLOGXSYM AND MECHANISTIC TOXICITY DATA FROM A BIOMIMETIC LIVER MICROPHYSIOLOGY SYSTEM PREDICTS BIOLOGICS-INDUCED LIVER INJURY (BILI) FOR MULTIPLE LARGE MOLECULES.

PWII-004 - MITIGATING CARDIOTOXICITY OF TRASTUZUMAB AND DOXORUBICIN COMBINATION THERAPY WITH AN INTEGRATED TRANSLATIONAL AND QUANTITATIVE SYSTEMS TOXICOLOGY AND PBPK/PD MODELING APPROACH